Service Industries Limited (PSX:SRVI)

Revance Therapeutics Revenue

Service Industries had revenue of 32.52B PKR in the quarter ending March 31, 2025, with 10.46% growth. This brings the company's revenue in the last twelve months to 128.09B, up 19.90% year-over-year. In the year 2024, Service Industries had annual revenue of 125.01B with 29.52% growth.

• Revenue (ttm): 128.09B
• Revenue Growth: +19.90%
• P/S Ratio: 0.42
• Revenue / Employee: 8.56M
• Employees: 14,966
• Market Cap: 53.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	125.01B	28.49B	29.52%
Dec 31, 2023	96.52B	34.85B	56.51%
Dec 31, 2022	61.67B	22.28B	56.58%
Dec 31, 2021	39.39B	8.23B	26.40%
Dec 31, 2020	31.16B	1.10B	3.67%